$GSK Company News U.K. stocks pare losses after inflation

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2013 at 11:25 PM

$GSK Company News

U.K. stocks pare losses after inflation data 12:00 p.m. Today - Sara Sjolin
FTSE 100 climbs for third day, Aggreko rallies 1:31 p.m. Oct. 28, 2013 - Sara Sjolin
Glaxo, miners pull FTSE 100 from five-month high 12:26 p.m. Oct. 23, 2013 - Sara Sjolin
Banks hit Europe after ECB stress-test news 12:04 p.m. Oct. 23, 2013 - Sara Sjolin
Drug-maker earnings come in ahead of views, but stocks aren't rewarded 11:45 a.m. Oct. 23, 2013 - blogs.marketwatch.com
GSK sales to China down 61% on bribery probe 7:42 a.m. Oct. 23, 2013 - MarketWatch.com
5 of the biggest corporate fines ever 2:40 p.m. Oct. 21, 2013 - Jonnelle Marte
GSK sells thrombosis brands to Aspen for $1.13 bln 7:46 a.m. Sept. 30, 2013 - MarketWatch.com
J.P. Morgan launches fund with Gates Foundation 10:17 a.m. Sept. 23, 2013 - MarketWatch.com
BlackBerry plunges as it slashes jobs, forecasts 4:57 p.m. Sept. 20, 2013 - Saumya Vaishampayan
Two upgrades, two downgrades from Barclays on Euro drug makers 12:46 p.m. Sept. 16, 2013 - blogs.marketwatch.com
U.K.’s FTSE 100 rises to six-week high 12:40 p.m. Sept. 16, 2013 - Sara Sjolin
FDA votes for GSK, Thereavance lung-disease drug 2:50 a.m. Sept. 11, 2013 - MarketWatch.com
Mylan shares jump after FDA lays out guidelines for asthma generic 2:47 p.m. Sept. 10, 2013 - blogs.marketwatch.com
Miners, banks lead FTSE higher after China data 12:16 p.m. Sept. 10, 2013 - Sara Sjolin
European stocks rally after upbeat China data 12:10 p.m. Sept. 10, 2013 - Sara Sjolin
Asian shares rise on upbeat Chinese data 4:55 a.m. Sept. 10, 2013 - Daniel Inman
BG leads FTSE 100 lower after forecast downgrade 12:08 p.m. Sept. 9, 2013 - Sara Sjolin
GSK sells Lucozade, Ribena to Suntory for $2.1 bln 4:09 a.m. Sept. 9, 2013 - MarketWatch.com
U.S. expands Glaxo probe to include China 11:21 a.m. Sept. 7, 2013 - MarketWatch.com

GlaxoSmithKline Drug Falls Short, Sarepta Shares Collapse, and 3 More Hot Stocks 11:56 a.m. Today - Wall St. Cheat Sheet
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen (Updated) 10:25 a.m. Today - TheStreet.com
GSK Pivotal Phase III Study of Darapladib in Chronic Coronary Heart Disease Gid Not Meet Primary Endpoint 5:11 a.m. Today - benzinga.com
Pre-Market Activity Shows Heavy Volume And Movement For GlaxoSmithKline (GSK) 8:56 a.m. Nov. 11, 2013 - TheStreet.com
China Biotech In Review: Cytori Signs $531 Million Deal With New Australian Company 3:22 a.m. Nov. 10, 2013 - Seeking Alpha
4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Nov. 8, 2013 - Seeking Alpha
Make A Suave Move, Buy Novartis 2:37 p.m. Nov. 8, 2013 - Seeking Alpha
GlaxoSmithKline: Offering Stable And Juicy Dividend Yield 1:42 p.m. Nov. 8, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Merck Looks Like a Relative Bargain 6:00 a.m. Nov. 8, 2013 - TheStreet.com
Agenus Valuation After Positive HerpV Vaccine Results 2:46 p.m. Nov. 7, 2013 - Seeking Alpha
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
These 48 Blue Chips Are On the Move 4:40 a.m. Nov. 6, 2013 - InvestorPlace.com
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Will GlaxoSmithKline Get Away in China? 5:10 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Update on Glaxo's Respiratory Portfolio - Analyst Blog 4:30 p.m. Nov. 4, 2013 - Zacks.com
Johnson & Johnson Agrees to $2B DOJ Settlement 11:08 a.m. Nov. 4, 2013 - FOXBusiness
GlaxoSmithKline Dodges China Bullet, Dish-Disney Deal Remains Elusive, and 2 More Hot Stocks 11:07 a.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Why I'm More Confident in Sarepta Than Ever Before 10:06 a.m. Nov. 4, 2013 - TheStreet.com
Pfizer's Not Losing Its Kingpin Status 6:00 a.m. Nov. 4, 2013 - TheStreet.com

WPP'S GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline 3:26 p.m. Nov. 11, 2013 - PR Newswire
Morning Research: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. 8:00 a.m. Nov. 11, 2013 - PR Newswire
Upcoming Presentations, New Studies, and Stock Price Movements - Research Report on WellPoint, GSK, Forest Laboratories, Intuitive Surgical, and Cubist Pharmaceuticals 8:00 a.m. Nov. 11, 2013 - PR Newswire
Cannabis Biotech Files Patent Application for Metered-Dose Dispensing Device 8:30 a.m. Nov. 4, 2013 - BusinessWire
Media Advisory: GSK Recalls Two Lots of Migraine Medication: IMITREX Injection 5:52 p.m. Nov. 1, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
BREO® ELLIPTA(TM) now available in the U.S. for the treatment of COPD 10:09 a.m. Oct. 30, 2013 - PR Newswire
Critical Alerts For GlaxoSmithKline, Deutsche Bank, Cummins, Canadian Solar, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 30, 2013 - PR Newswire
BREO(R) ELLIPTA(TM) Now Available in the U.S. for the Treatment of COPD 9:01 a.m. Oct. 30, 2013 - Marketwire
Cannabis Biotech in Talks With Research Chemist to Explore Transmucosal Delivery 8:30 a.m. Oct. 29, 2013 - BusinessWire
FDA Approval, FDA Application, Positive Safety Results, and Presentations - Research Report on Cubist, GSK, Rockwell Medical, Arrowhead, and Horizon Pharma 8:00 a.m. Oct. 24, 2013 - PR Newswire
Lamotrigine is One of the Most Commonly Prescribed Drugs Among Newly Diagnosed Bipolar Disorder Patients in the United States 8:00 a.m. Oct. 23, 2013 - PR Newswire
GlaxoSmithKline CFO Interviewed on Q3 results 7:56 a.m. Oct. 23, 2013 - PR Newswire
ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV 12:53 p.m. Oct. 22, 2013 - PR Newswire
At One Month Post-Launch, Nearly a Quarter of Surveyed U.S. Oncologists Have Prescribed Tafinlar for Malignant Melanoma, Compared to 15 Percent Who Used Mekinist 11:43 a.m. Oct. 22, 2013 - PR Newswire
Maxalt/Maxalt MLT is the Most Commonly Prescribed Branded Triptan Used by Newly Diagnosed Migraine Patients in the United States 10:00 a.m. Oct. 22, 2013 - PR Newswire
Cannabis Biotech Launches Development of Transmucosal Delivery System 8:30 a.m. Oct. 21, 2013 - BusinessWire
Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx 8:00 a.m. Oct. 18, 2013 - PR Newswire
Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. 12:51 p.m. Oct. 17, 2013 - PR Newswire
Medivir: Janssen Has Acquired an NS5a Replication Complex Inhibitor That Will Be Evaluated with Simeprevir in Future Clinical Development 9:06 a.m. Oct. 8, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jersey Teamsters Stand Firm for Fair Health Worker Deal

ImageCare Workers Ready to Strike Normally, when we hear about health care, we're pretending it’s this well-oiled machine. But here we are, witnessing techs and aides at ImageCare gearing up to strike for the first time. Sussex County’s finest have had it up to their ears negotiating for a union contract that doesn’t treat them like an afterthought. Two-Year...

Tech Job Market Surges with AI and IT Skills Spike

Alright, folks, though we're not drowning in champagne just yet, there's a promising uptick in October's tech employment, signaling a rebound or at least some relief for tech pros and market watchers. CompTIA's numbers show a boost of 7,200 jobs in the tech industry while IT occupations expanded by 26,000 slots. That's no small feat when the general job scene elsewhere...

CorelDRAW's Flexibility: A Designer's One-Time Buy?

CorelDRAW: A Design Powerhouse Without Recurring Bills? Every so often, a software option comes along that piques my interest, and right now, it's CorelDRAW Graphics Suite. Consumer365 has shone a light on this nifty tool for its one-time purchase model—a breath of fresh air in the age of endless subscriptions that seem to drain more than enthusiasm as the months roll...

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

WIC 2026: Global Connectivity and Cyber Futures

Connectivity Takes Center Stage in Wuzhen When you throw 1,800 movers and shakers into a room focused on the future of the internet, sparks are gonna fly. That's exactly what's going down at the 2026 World Internet Conference in Wuzhen, China. Brass tacks: this ain't just another snooze-fest. The theme this year screams significance—'Open Source and Openness, Joined...

VS Pharmtech Enhances Cancer Drug Efficiency, Eyes IPO

Revolutionizing Cancer Care, One Dose at a Time Now, here's a twist worth chewing over your morning coffee: VS Pharmtech isn't concocting some newfangled miracle drug but is instead jazzing up the old ones. Their creation, VS-101, isn't just another treatment—it's a radiosensitizer designed to make existing therapies more potent without the toxic baggage. The Science...

Pre-Owned Jet Inventory Rises; Price Trends Unclear

October's Pre-Owned Aircraft Inventory: A Mixed Bag Nothing like leafing through October's data on pre-owned jets and feeling your stomach do that weird flip-flop. Inventory's nudging up, but it's still on its knees compared to last year's numbers. According to Sandhills Global's fresh aviation market reports, we got an increase in what's available on platforms like...

212NYC Gala Celebrates Ad Industry's Human Touch

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

QORAI CORP's Q4 Nexus: A New AI Frontier

Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...

Sass Magazine's 2026 COZY Issue Embraces Intentional Joy

An Unexpected Shift in Sass's Seasonal Focus When you think November and December, it's easy to picture the hustle and bustle of holiday preparations—shopping, parties, running around. But toss all that hullabaloo out the window, because Sass Magazine has thrown a curveball for their 2026 release. They're steering the ship towards the calm, with their COZY Issue shaping...